[Sarcoidosis occurring after chemotherapy for breast cancer: Difficulty of drug causality assessment]

Kévin Didier; Isabelle Beguinot; Malak Abou-Taam; Amélie Servettaz; Firouze Bani-Sadr

doi:10.1016/j.therap.2017.05.001

[Sarcoidosis occurring after chemotherapy for breast cancer: Difficulty of drug causality assessment]

Therapie. 2017 Dec;72(6):705-708. doi: 10.1016/j.therap.2017.05.001. Epub 2017 May 26.

[Article in French]

Authors

Kévin Didier¹, Isabelle Beguinot², Malak Abou-Taam³, Amélie Servettaz¹, Firouze Bani-Sadr⁴

Affiliations

¹ Service de médecine interne, d'immunologie clinique et de maladies infectieuses et tropicales, hôpital Robert-Debré, CHU de Reims, 51092 Reims, France.
² Service de médecine interne, centre hospitalier Emile-Durkheim, 88000 Épinal, France.
³ Centre régional de pharmacovigilance et d'information sur le médicament, CHU de Reims, 51092 Reims, France.
⁴ Service de médecine interne, d'immunologie clinique et de maladies infectieuses et tropicales, hôpital Robert-Debré, CHU de Reims, 51092 Reims, France. Electronic address: [email protected].

PMID: 28647105
DOI: 10.1016/j.therap.2017.05.001

No abstract available

Keywords: Breast cancer; Cancer du sein; Post-cancer sarcoidosis; Post-chemotherapy sarcoidosis; Sarcoidosis; Sarcoïdose; Sarcoïdose post-chimiothérapie.

Publication types

Case Reports
Letter

MeSH terms

Adenocarcinoma / drug therapy*
Antineoplastic Agents / administration & dosage
Antineoplastic Agents / adverse effects*
Breast Neoplasms / drug therapy*
Female
Humans
Middle Aged
Sarcoidosis / chemically induced*
Sarcoidosis / diagnosis

Substances

Antineoplastic Agents